ArcticZymes

As part of the effort, Virus.X also aims to craft new sequencing approaches, bioinformatics tools, and targeted gene products.

The Biotec Pharmacon subsidiary is taking part in the Virus-X EU Consortium by developing new viral enzymes and bringing them to the market.

ArcticZymes said last week that it has inked a supply agreement with GE Healthcare Life Sciences for products based on ArcticZymes' portfolio of heat-labile enzymes.

ArcticZymes and New England Biolabs have signed a supply agreement for ArcticZymes' recombinant shrimp alkaline phosphatase, or SAP, enzyme.

By Ben Butkus
ArcticZymes, a Norwegian life science research tools firm specializing in cold-adapted and heat-labile enzymes for use in molecular biology and diagnostics, this week opened its first US office in the outskirts of Philadelphia.

ArcticZymes has named Brent Spoth as business development manager for the Americas.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Biotec Pharmacon today announced it has reached a new non-exclusive deal with Affymetrix for the distribution of ArcticZymes' shrimp alkaline phosphatase (SAP).

TATAA will sell ArcticZymes' heat-labile enzymes for use in contamination control through its sales channels; and will integrate ArcticZymes' products into its range of courses.

The companies will sell each other's products in Europe.

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.